KTE-X19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, in Patients (Pts) with Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL): Results of the Phase 2 ZUMA-2 Study
| Image |  |
|---|---|
| Description | scholarly article |
| Author/s | |
| Publication date | March 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Access work |
https://linkinghub.elsevier.com/retrieve/pii/S1083879119309978 |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |